SLN, a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and ...
Congress established the Office of Science and Technology Policy (OSTP) in 1976 to provide the President and Executive Office of the President (EOP) with advice on the scientific, engineering, and ...